Small biotech trials succeed or fail on clinical supply discipline, where forecasting, comparator sourcing, and global execution determine whether patients stay on treatment.
- From Inconsistency To Structure: A Model For Defensible Compliance Decisions
- Building Resilient Clinical Supply Chains To Keep Trials On Track
- Randomization And Trial Supply Management (RTSM) Systems: Meet Your Neighbor Again
- Real-World Data Is Reshaping How We Supply Clinical Trials — And It's About Time
- Why Good Data Still Fails: Inconsistency, Visibility, And Decision Risk
- Designing CNS Trial Supply Chains: A Technical Framework
- Primary Healthcare Disruption And Clinical Trial Supply Risk
- Protecting Clinical Trials From Global Supply Disruptions
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Key Considerations For Packaging Solutions For Cell And Gene Therapies
Thinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
-
Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy
Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.
-
CDMO Support: Success In Early-Phase Drug Product Development
As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering specialized expertise, accelerated timelines, cost efficiency, and risk mitigation.
-
Developing Injectable Drug Placebo Formulations For Clinical Trials
Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
3 Reasons Sponsors Should Own The RTSM Vendor Relationship
Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.
-
Advancing Your API To First Human Dose Trials More Efficiently
Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
Web-Based CDR System: Precision Without Compromise
Validated research confirms that web-based cognitive testing maintains the millisecond precision of traditional hardware, ensuring high-quality data for decentralized clinical trials.
-
Ensuring On-Time Release Of CAR-T Cell Treatment In Spain
Due to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
Overcome The Supply Chain Complexities Of Vaccine Development
Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.